Delivery Order SPE2DB24D8002-SPE2DB25FJMYL
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in the System for Award Management (SAM.gov). The $13,783.74 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a performance period through November 19, 2024 and was awarded on November 18, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,477.84, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract is structured as a firm fixed-price delivery order with a completion date of September 10, 2024.
Dakota Drug, Inc. also holds a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The $2,066.94 firm fixed price delivery order has a completion date of November 1, 2024 and is not set aside. Dakota Drug, Inc. holds a large single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division's ECAT Generation V Program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,479.21 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a performance period through August 15, 2024.
Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program,...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,039.84 and a period of performance through October 21, 2024. Dakota Drug, Inc. is also the holder of a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,232.70 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. This contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription pharmaceutical product. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,250.46 firm fixed-price delivery order is for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication.
The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award, valued at $1,252.44, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes.
The contract is a firm fixed-price delivery order without a set-aside designation. It has an ultimate completion date of August 1, 2024. Dakota Drug, Inc. holds...
The Defense Logistics Agency (DLA) awarded a $3,035.35 firm-fixed-price delivery order contract (SPE2DB25FKZAE) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug's larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) with the DLA Troop Support Medical division's ECAT Generation V Program, which allows the company to provide a wide range of...